Pharmaceutical Companies in Denmark

Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.

AFYX Therapeutics is a private biopharmaceutical company focused on innovative approaches to treat mucosal diseases. The Company has developed the Rivelin patch, a breakthrough therapy for the treatment of mucosal diseases. Rivelin is designed to deliver a pharmaceutical drug uni-directionally to a mucosal surface using an occlusive, bio-adhesive and bio-degradable patch, with a long adhesion time and a high flexibility, conforming to the mucosal surface. AFYX's lead Rivelin patch product candidate seeks to treat the auto-immune, inflammatory disease oral lichen planus (OLP) through direct delivery of the drug clobetasol propionate. OLP may appear as lesions in the mouth that may cause burning, pain and other discomfort. OLP is considered an autoimmune disorder and requires regular monitoring given patients have increased risk of developing mouth cancer in the affected areas. No U.S. Food and Drug Administration (FDA) approved treatment exists, with today’s off-label treatment ranging from topical corticosteroids to laser ablation. It is estimated that OLP affects 1% to 2% of the population. Following successful results from a Phase 1b clinical study of the non-drug-loaded Rivelin patch in patients with OLP, AFYX has begun a Phase 2b clinical study of the clobetasol-loaded Rivelin patch in the United States and various countries in Europe. Shareholders include Sofinnova Ventures, Lundbeckfonden Emerge, Novo Seeds and Welfare Tech Invest.

Mission NMD Pharma is dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular disease. Vision A future in which patients with neuromuscular disease live better and more independent lives. We have a unique translational muscle electrophysiology platform leveraging in-depth know-how of muscle physiology and muscular disorders for discovering and developing first-in-class therapeutics in neuromuscular diseases with a significant unmet medical need. NMD Pharma is the leading company utilizing ClC-1 Cl- ion channel inhibitors for neuromuscular diseases and currently has one clinical-stage product candidate for the treatment of myasthenia gravis. We have more than 25 employees with expertise in all areas of drug development. We are headquartered in Aarhus, Denmark, and collaborate with internationally renowned companies and key opinion leaders in the field of neuromuscular diseases. For more information, please visit the company website.

ApoPro.dk er apoteket som du kender det - bare online. ApoPro.dk tilbyder receptmedicin, håndkøbsmedicin og andre apoteksvarer leveret diskret til døren. Her får du direkte kontakt med en veluddannet farmaceut eller farmakonom med adgang til både din medicinliste og en database af ny viden. ApoPro.dks fagpersonale sidder klar til at hjælpe og rådgive dig via telefon, chat, videosamtaler, mail eller på sitet. Det er altid muligt at være anonym. ApoPro.dk er godkendt af Lægemiddelstyrelsen, E-mærket og medlem af Danmarks Apotekerforening Kundesupport er åben: Mandage: 8.00 - 17.00 Tirsdag - fredag: 8.00 - 16.30 Lørdage: 9.00 - 13.00 E-mails besvares inden for 24 timer på hverdage Ventrupvej 27, 2670 Greve Dortheavej 12, 2400 København NV

At Ellab, our mission is to reduce the time-to-market and risk of product loss for biotech and pharma companies across the globe. We do so through our reliable validation products and field services, continuous monitoring solutions, GMP consulting, and calibration services. As a validation and monitoring tech and service partner, we help biopharmaceutical companies meet compliance requirements and deadlines today, and tomorrow – allowing us to build confidence in consumer safety together. One way we’ve successfully done this, was during the COVID-19 pandemic, where our solutions enabled our customers to validate that their freezers were safe to store Covid vaccines – ultimately ensuring that they were safe use.

Orifarm is one of the largest European suppliers of parallel imported and generic pharmaceuticals. We provide high-quality pharmaceuticals at a low cost, and our ambition is to be the number one in making healthcare a better deal while creating value and savings for society and consumers. Internationally, we work together to fulfill our vision, always exploring new business areas to drive Orifarm to new heights.